United Therapeutics Corporation DSO Ratio 2011-2026 | UTHR

Annual DSO Ratio United Therapeutics Corporation

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
36.1	35.4	39.2	39.5	38.6	38	38.1	39.4	62.9	49	48	46	41.3	46.5	43.6

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
62.9	35.4	42.8

Quarterly DSO Ratio United Therapeutics Corporation

2025-Q2	2025-Q1	2024-Q4	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
40.1	34.5	-	38.5	38.2	39.5	-	39.8	31.1	31.9	-	20.5	16.7	36.5	-	39.6	32.1	35.9	-	37.8	39.7	39.5	44.4	34.4	37	41.2	42	38.9	36.1	55.4	58.3	60.9	61	63	47.9	48	47.4	50.4	43.5	45.5	50.7	49.5	42.8	44.9	45.9	45.5	39.9	38.1	41.1	45.2	43.6	43.9	47.2	45.9	41.5	40.1	44	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
63	16.7	42.2

DSO Ratio of other stocks in the Biotechnology industry

Issuer	DSO Ratio	Price	% 24h	Market Cap	Country
I-Mab IMAB	271	-	-	$ 866 M	China
Alexion Pharmaceuticals, Inc. ALXN	84.7	-	-	$ 40.3 B	USA
AgeX Therapeutics AGE	78.4	-	-10.17 %	$ 12.2 K	USA
Aeglea BioTherapeutics AGLE	216	-	-	$ 1.01 B	USA
Codexis CDXS	32.9	$ 1.02	1.49 %	$ 74.9 M	USA
AbCellera Biologics ABCL	173	$ 3.74	3.6 %	$ 1.12 B	Canada
Applied Genetic Technologies Corporation AGTC	0.114	-	-	$ 26.5 M	USA
Cerus Corporation CERS	59.2	$ 2.6	1.37 %	$ 480 M	USA
EyeGate Pharmaceuticals, Inc. EYEG	2.75 K	-	-1.52 %	$ 24.7 M	USA
Midatech Pharma plc MTP	204	-	-18.52 %	$ 27.3 M	Britain
Cellectis S.A. CLLS	94.5	$ 3.87	-0.39 %	$ 116 M	France
Acorda Therapeutics ACOR	48.3	-	-24.86 %	$ 820 K	USA
Acasti Pharma ACST	1.97	-	4.01 %	$ 150 M	Canada
Adverum Biotechnologies ADVM	222	-	-	$ 86.2 M	USA
AIkido Pharma AIKI	17.9	-	1.93 %	$ 17.4 M	USA
Collegium Pharmaceutical COLL	391	$ 41.75	0.19 %	$ 1.32 B	USA
Albireo Pharma ALBO	14.7	-	-0.23 %	$ 916 M	USA
Corcept Therapeutics Incorporated CORT	27.3	$ 36.14	1.23 %	$ 3.75 B	USA
Amarin Corporation plc AMRN	157	$ 13.98	1.27 %	$ 5.7 B	Irlanda
Catalyst Pharmaceuticals CPRX	59.5	$ 23.77	2.99 %	$ 2.91 B	USA
Alpine Immune Sciences ALPN	154	-	-	$ 2.17 B	USA
Corbus Pharmaceuticals Holdings CRBP	239	$ 8.41	-1.87 %	$ 36.4 M	USA
Cardiff Oncology CRDF	294	$ 1.94	0.01 %	$ 130 M	USA
Curis CRIS	103	$ 1.1	-3.51 %	$ 6.94 M	USA
Aeterna Zentaris AEZS	146	-	5.93 %	$ 314 M	Canada
CorMedix CRMD	127	$ 7.16	0.42 %	$ 364 M	USA
Champions Oncology CSBR	66.5	$ 6.14	3.89 %	$ 83.9 M	USA
Aravive ARAV	16.8	-	-13.39 %	$ 1.45 M	USA
Aptinyx APTX	46.9	-	-39.0 %	$ 4.57 M	USA
Aridis Pharmaceuticals ARDS	59	-	17.91 %	$ 11.1 M	USA
Altimmune ALT	15.1 K	$ 4.21	-2.32 %	$ 299 M	USA
CEL-SCI Corporation CVM	227	$ 3.88	-8.92 %	$ 247 M	USA